NEW ISSUE
CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR
August 7, 2020
Showing 1-8 of 8 articles
Interventions for valvular disease
Thirty-day Clinical Outcomes of the Evolut PRO Self-Expanding Transcatheter Aortic Valve: The International FORWARD PRO Study August 4, 2020 | 10.4244/EIJ-D-20-00279
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients September 20, 2017 | 10.4244/EIJ-D-16-01024
Coronary interventions
Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program January 20, 2017 | 10.4244/EIJ-D-16-00079
Interventions for valvular disease
TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery September 18, 2016 | 10.4244/EIJV12SYA6
Interventions for valvular disease
Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system August 20, 2016 | 10.4244/EIJV12I6A125
First-in-man Portico® transcatheter aortic valve-in-valve implantation in a degenerated 19 mm Mitroflow® aortic pericardial heart valve
March 20, 2014 | 10.4244/EIJV9I11A229
St Jude Medical Portico valve
September 30, 2012 | 10.4244/EIJV8SQA18
Complications of transcatheter aortic valve implantation: avoidance and management
September 30, 2011 | 10.4244/EIJV7I5A99